Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
7,484,952
-
Share change
-
+656,926
-
Total reported value
-
$89,888,326
-
Price per share
-
$12.01
-
Number of holders
-
39
-
Value change
-
+$7,850,421
-
Number of buys
-
18
-
Number of sells
-
13
Institutional Holders of ELOXX PHARMACEUTICALS INC - COM (ELOX) as of Q4 2018
As of 31 Dec 2018,
ELOXX PHARMACEUTICALS INC - COM (ELOX) was held by
39 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,484,952 shares.
The largest 10 holders included
MENORA MIVTACHIM HOLDINGS LTD., BlackRock Inc., Vanguard Group Inc, Altshuler Shaham Ltd, MEITAV DASH INVESTMENTS LTD, STATE STREET CORP, NORTHERN TRUST CORP, GEODE CAPITAL MANAGEMENT, LLC, EMERALD MUTUAL FUND ADVISERS TRUST, and New England Private Wealth Advisors LLC.
This page lists
39
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.